TCF7L1 has been shown to play an oncogenic role in CRC by repressing expression of known CRC tumor suppressor ephrin type-B receptor 3 (EPHB3) and the Wnt antagonist Dickkopf4 (DKK4) [9,10]. This evidence concerns the gene TCF7L1 and colorectal carcinoma.